Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Blood Vessel Growth Research Surges as Angiogenesis Science Reaches New Heights

October 10, 2026
Continue Reading
blood-vessel-growth-research-surges-as-angiogenesis-science-reaches-new-heights
Posted inBiotechnology

Wild Rosehips in Türkiye’s Mountains Reveal Striking Vitamin C and Antioxidant Diversity

October 10, 2026
Continue Reading
wild-rosehips-in-turkiye’s-mountains-reveal-striking-vitamin-c-and-antioxidant-diversity
Posted inBiotechnology

Men and Women With Metabolic Syndrome Carry Distinctly Different Chemical Fingerprints, Massive Review Finds

October 10, 2026
Continue Reading
men-and-women-with-metabolic-syndrome-carry-distinctly-different-chemical-fingerprints,-massive-review-finds
Posted inBiotechnology

Antibody Sensors Race to Catch Pesticides and Fungal Toxins in Our Food

October 10, 2026
Continue Reading
antibody-sensors-race-to-catch-pesticides-and-fungal-toxins-in-our-food
Posted inBiotechnology

Massive NIH Database Study Probes How Lifestyle, Diet and Treatment Shape Rosacea

October 10, 2026
Continue Reading
massive-nih-database-study-probes-how-lifestyle,-diet-and-treatment-shape-rosacea
Posted inBiotechnology

Gut Cancer Gene GLIS3 Found to Fuel Tumors Through a Vitamin B6 Enzyme and Autophagy

October 10, 2026
Continue Reading
gut-cancer-gene-glis3-found-to-fuel-tumors-through-a-vitamin-b6-enzyme-and-autophagy
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

novartis,-bioage-take-on-age-related-diseases-in-$550m-pact
Posted inBiotechnology

Novartis, BioAge take on age-related diseases in $550M pact

December 18, 2024
Freshly public BioAge Labs has secured a multi-year partnership with Novartis that focuses on age-related diseases and includes the possibility…
Read More
roche-to-bring-mass-spec-to-routine-labs-with-new-cobas-system’s-european-approval
Posted inMedical Technology

Roche to bring mass spec to routine labs with new cobas system’s European approval

December 18, 2024
Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to…
Read More
fibrosis-focused-tvardi-to-go-public-via-merger-with-cash-strapped-cara
Posted inBiotechnology

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

December 18, 2024
Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…
Read More
merck-&-co.-boosts-glp-1-portfolio-by-paying-$112m-upfront-for-hansoh’s-preclinical-drug
Posted inBiotechnology

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

December 18, 2024
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for…
Read More
aurion’s-regenerative-eye-disease-med-improves-vision-in-phase-1/2-trial
Posted inBiotechnology

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

December 18, 2024
The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has improved…
Read More
cognition’s-phase-2-shimmer-results-finally-allow-dementia-drug-to-shine
Posted inBiotechnology

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

December 18, 2024
The failure of Cognition Therapeutics’ Alzheimer’s disease candidate CT1812 in the SHINE trial earlier this year may have rubbed off…
Read More
nvidia’s-venture-arm-raises-stake-in-ai-drug-discoverer-genesis-therapeutics
Posted inGenetics

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

December 18, 2024
Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics In the beginning, Genesis Therapeutics spun out from the Stanford University…
Read More
how-the-inflammatory-process-is-influenced-by-the-circadian-rhythm
Posted inGenetics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

December 18, 2024
There are various studies that have explored the role of the body’s circadian rhythm in regulating immune activity. Disruptions in…
Read More
novo-nordisk-taps-photys-for-$186m-cardiometabolic-collab
Posted inBiotechnology

Novo Nordisk taps Photys for $186M cardiometabolic collab

December 17, 2024
With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a concerted…
Read More
novo-holdings-leads-siteone’s-$100m-series-c-for-non-opioid-pain-treatments
Posted inBiotechnology

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

December 17, 2024
SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral…
Read More

Posts pagination

Previous page 1 … 2,418 2,419 2,420 2,421 2,422 … 2,429 Next page
You May Have Missed
Posted inMedical Technology

VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system

Posted inMedical Technology

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

Posted inMedical Technology

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Posted inMedical Technology

Adagio Medical kicks off strategic review, trims more than half its staff

Privacy Policy    Terms

Scroll to Top